One of the most exciting and clinically relevant observations was the discovery that a high percentage of secondary glioblastomas and a very small percentage of primary glioblastoma harbor mutations in the isocitrate dehydrogenase 1 (IDH1) gene. The gene discussed is IDH1; the disease is glioblastoma.